Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

4429693 Title: ANNEXINE A5 MONOMÈRE POUR UNE UTILISATION DANS LE TRAITEMENT DE L'OEDÈME MACULAIRE OU D'UNE OCCLUSION D'UNE VEINE RÉTINIENNE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
237307186
WO application number:
EP2023063441
Type:
European patent granted for BE
Status:
Open
Publication number:
4429693
WO publication number:
WO2023227468
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
18/05/2023
Grant date:
26/02/2025
EP publication date:
18/09/2024
WO publication date:
30/11/2023
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
26/02/2025
EP B1 publication date:
26/02/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
18/05/2043

Applicant

Name:
Annexin Pharmaceuticals AB
Legal Form:
From:
26/02/2025
Address:
Kammakargatan 48, 111 60 Stockholm, Sweden (SE)
To:

Agent

Name:
NLO
Legal Form:
From:
22/05/2025
Address:
New Babylon City Offices Anna van Buerenplein 21A, 2595 DA DEN HAAG, Netherlands (NL)
To:

Inventor

1

Name:
FROSTEGÅRD, Anna
Legal Form:
Address:
11160 Stockholm, Sweden (SE)

2

Name:
HAEGERSTRAND, Anders
Legal Form:
Address:
11160 Stockholm, Sweden (SE)

Priority

Priority patent number:
202207263
Priority date:
18/05/2022
Priority country:
United Kingdom (GB)

Classification

IPC or IDT classification:
A61K 38/17; A61P 27/02;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2025/04
Publication date:
15/05/2025
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202509
Publication date:
26/02/2025
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
01/06/2026
Annual fee number:
4
Annual fee amount:
55 Euro
Expected payer:
Last annual fee payment date:
30/06/2025
Last annual fee paid number:
3
Last annual fee paid amount:
40 Euro
Payer:
NEDERLANDSCH OCTROOIBUREAU NV
Filing date Document type Publication Type Document Description Number of pages File Type
22/05/2025 General Document Declaration of domicile 2 PDF /1/7/3/4/1/0722514371/docs/237307186_0_generaldocument_20250523_084523775.pdf
22/05/2025 Incoming Correspondence (Email) Cover letter 1 PDF /1/7/3/4/1/0722514371/docs/237307186_1_incomingcorrespondenceelectronic_20250523_084523863.pdf
22/05/2025 Outgoing Correspondence 1 PDF /1/7/3/4/1/0722514371/docs/237307186_2_outgoingcorrespondence_20250523_084523689.pdf